Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean P Collins

Showing results (321-330 of 428) with videos related to

Pageof 43
Sort By:
Hypertension (Dallas, Tex. : 1979)|January 30, 2026
Galectin-1 Is a Marker but Not a Mediator of Heart Failure With Preserved Ejection FractionJean W Wassenaar, C Duncan Smart, Daniel J Fehrenbach, et al.
Frontiers in Oncology|November 30, 2020
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate CancerNima Aghdam, Abigail N Pepin, Michael Creswell, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 8, 2017
Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHFGad Cotter, Beth A Davison, Javed Butler, et al.
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
Plos One|October 30, 2013
MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214Anvesha Srivastava, Helle Goldberger, Alexander Dimtchev, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Heart Failure Reviews|April 29, 2025
A spotlight on congestion in acute heart failure: a joint session with the Romanian Society of Cardiology (part I)Linda Ye, Alex J Chang, Ovidiu Chioncel, et al.
JAMA Network Open|January 10, 2024
Short-Stay Units vs Routine Admission From the Emergency Department in Patients With Acute Heart Failure: The SSU-AHF Randomized Clinical TrialPeter S Pang, David A Berger, Simon A Mahler, et al.
American Heart Journal|December 1, 2012
Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studiesSean P Collins, Christopher J Lindsell, Cathy A Jenkins, et al.
JACC. Heart Failure|October 10, 2015
Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision ToolSean P Collins, Cathy A Jenkins, Frank E Harrell, et al.
Pageof 43

Showing results (321-330 of 428) with videos related to

Sort By:
Pageof 43
Hypertension (Dallas, Tex. : 1979)|January 30, 2026
Galectin-1 Is a Marker but Not a Mediator of Heart Failure With Preserved Ejection FractionJean W Wassenaar, C Duncan Smart, Daniel J Fehrenbach, et al.
Frontiers in Oncology|November 30, 2020
Management of Isolated Local Failures Following Stereotactic Body Radiation Therapy for Low to Intermediate Risk Prostate CancerNima Aghdam, Abigail N Pepin, Michael Creswell, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 8, 2017
Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHFGad Cotter, Beth A Davison, Javed Butler, et al.
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
Plos One|October 30, 2013
MicroRNA profiling in prostate cancer--the diagnostic potential of urinary miR-205 and miR-214Anvesha Srivastava, Helle Goldberger, Alexander Dimtchev, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Heart Failure Reviews|April 29, 2025
A spotlight on congestion in acute heart failure: a joint session with the Romanian Society of Cardiology (part I)Linda Ye, Alex J Chang, Ovidiu Chioncel, et al.
JAMA Network Open|January 10, 2024
Short-Stay Units vs Routine Admission From the Emergency Department in Patients With Acute Heart Failure: The SSU-AHF Randomized Clinical TrialPeter S Pang, David A Berger, Simon A Mahler, et al.
American Heart Journal|December 1, 2012
Risk stratification in acute heart failure: rationale and design of the STRATIFY and DECIDE studiesSean P Collins, Christopher J Lindsell, Cathy A Jenkins, et al.
JACC. Heart Failure|October 10, 2015
Identification of Emergency Department Patients With Acute Heart Failure at Low Risk for 30-Day Adverse Events: The STRATIFY Decision ToolSean P Collins, Cathy A Jenkins, Frank E Harrell, et al.
Pageof 43